BillTrack50 logo
Free Signup Login
Bill

Bill > HB666

MD HB666

MD HB666
Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee

summary

Introduced
02/01/2017
In Committee
02/01/2017
Crossed Over
Passed
Dead
04/10/2017

Introduced Session

2017 Regular Session

Bill Summary

Requiring, on or before March 31 each year, the manufacturer of an expensive drug sold or offered for sale in the State to file with the Secretary of Health and Mental Hygiene a specified annual report; establishing the Drug Price Transparency Advisory Committee; requiring a manufacturer of an expensive drug to file a notice with the Secretary before increasing a specified price or a specified cost by more than a specified percentage or amount during specified periods of time; etc.

AI Summary

This bill requires, on an annual basis, the manufacturer of an "expensive drug" sold or offered for sale in the state to file a report with the Secretary of Health and Mental Hygiene providing detailed information about the drug, including research and development costs, intellectual property rights, production and marketing costs, pricing and revenue, financial assistance to patients, and comparative effectiveness. The bill also establishes a Drug Price Transparency Advisory Committee to advise the Secretary on the development of regulations and the review of the annual reports. Additionally, the bill requires manufacturers to provide advance notice to the Secretary before increasing the price of an expensive drug by more than certain thresholds, and imposes civil penalties for noncompliance.

Committee Categories

Health and Social Services

Sponsors (74)

Eric Bromwell (D)*,  Curtis Anderson (D),  Vanessa Atterbeary (D),  Charles Barkley (D),  Ben Barnes (D),  Darryl Barnes (D),  Kumar Barve (D),  Pamela Beidle (D),  Talmadge Branch (D),  Ben Brooks (D),  Alfred Carr (D),  Mark Chang (D),  Luke Clippinger (D),  Frank Conaway (D),  Bonnie Cullison (D),  Dereck Davis (D),  Kathleen Dumais (D),  Eric Ebersole (D),  Diana Fennell (D),  David Fraser-Hidalgo (D),  C. William Frick (D),  Barbara Frush (D),  Tawanna Gaines (D),  Cheryl Glenn (D),  Ana Gutierrez (D),  Keith Haynes (D),  Anne Healey (D),  Shelly Hettleman (D),  Terri Hill (D),  Sheila Hixson (D),  Marvin Holmes (D),  Carolyn Howard (D),  Michael Jackson (D),  Sally Jameson (D),  Adrienne Jones (D),  Anne Kaiser (D),  Ariana Kelly (D),  Tony Knotts (D),  Marc Korman (D),  Carol Krimm (D),  Stephen Lafferty (D),  Clarence Lam (D),  Robbyn Lewis (D),  Brooke Lierman (D),  Mary Ann Lisanti (D),  Eric Luedtke (D),  Cory McCray (D),  Maggie McIntosh (D),  Aruna Miller (D),  David Moon (D),  Marice Morales (D),  Nathaniel Oaks (D),  Edith Patterson (D),  Joseline Peña-Melnyk (D),  Andrew Platt (D),  Elizabeth Proctor (D),  A. Shane Robinson (D),  Sandy Rosenberg (D),  Sheree Sample-Hughes (D),  Carlo Sanchez (D),  Theodore Sophocleus (D),  Dana Stein (D),  Charles Sydnor (D),  Jimmy Tarlau (D),  Frank Turner (D),  Kris Valderrama (D),  Joseph Vallario (D),  Jeff Waldstreicher (D),  Jay Walker (D),  Alonzo Washington (D),  Mary Washington (D),  C.T. Wilson (D),  Karen Young (D),  Pat Young (D), 

Last Action

Hearing 2/23 at 1:00 p.m. (on 02/23/2017)

bill text

bill summary

Loading...

bill summary

Loading...
Loading...